Genzyme
Termeer exit could help Sanofi
September 30, 2010Sales and Marketing Genzyme, M&A, MA, Sanofi
Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …
Genzyme planning 1,000 job cuts
September 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts
Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
Genzyme available for ‘fair value’, says Termeer
September 2, 2010Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …
Sanofi’s $18.5bn bid for Genzyme rejected
August 31, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
Cohn & Wolfe wins MS account
August 20, 2010Medical Communications Cohn & Wolfe, Genzyme, MS
Cohn & Wolfe has won a global account with Genzyme to handle communications for its work with alemtuzumab in multiple …
Cell therapy industry partnership launched
August 18, 2010Research and Development Genzyme, ISCT, Lonza, Roche
Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
Genzyme posts loss after inventory write-off
August 12, 2010Manufacturing and Production, Sales and Marketing Genzyme, manufacturing compliance
Genzyme has had to write off an additional tranche of product that does not meet quality standards, forcing it to …
Sanofi’s blockbusters take a hit
July 29, 2010Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis
Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …
Genzyme ponders Sanofi offer
July 27, 2010Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis is understood to have approached the board of Genzyme with a takeover bid for the company. News agency Reuters …
Manufacturing woes hit Genzyme results
July 22, 20102010 financials, Genzyme, Q2
Genzyme has posted a decrease in sales for the second quarter as its manufacturing woes continue. The US-based biopharma company …
Genzyme says it will double size of its Framingham site
July 13, 2010Manufacturing and Production Genzyme
Genzyme has unveiled a major expansion of its manufacturing facility in Framingham, Massachusetts, which suggests that the company intends to …
EMA panel advises Fabrazyme switch
July 7, 2010Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance
Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …
More woe for Genzyme as shipping delays continue
July 6, 2010Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance
Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …
Digital Pharma: Byte-sized roundup
June 18, 2010Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media
This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
Genzyme and Icahn agree compromise deal
June 10, 2010Research and Development, Sales and Marketing Genzyme
Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
Latest content
Artificial hearts: a century of innovation
